151 related articles for article (PubMed ID: 35378127)
1. Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1 receptor.
Girdhar K; Thakur S; Gaur P; Choubey A; Dogra S; Dehury B; Kumar S; Biswas B; Dwivedi DK; Ghosh S; Mondal P
J Biol Chem; 2022 May; 298(5):101889. PubMed ID: 35378127
[TBL] [Abstract][Full Text] [Related]
2. miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.
Jo S; Chen J; Xu G; Grayson TB; Thielen LA; Shalev A
Diabetes; 2018 Feb; 67(2):256-264. PubMed ID: 29101219
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets.
Hall E; Dayeh T; Kirkpatrick CL; Wollheim CB; Dekker Nitert M; Ling C
BMC Med Genet; 2013 Jul; 14():76. PubMed ID: 23879380
[TBL] [Abstract][Full Text] [Related]
4.
Li W; Li P; Li R; Yu Z; Sun X; Ji G; Yang X; Zhu L; Zhu S
DNA Cell Biol; 2020 Sep; 39(9):1700-1710. PubMed ID: 32721233
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-related peptides from phylogenetically ancient fish reveal new approaches to the development of dual GCGR and GLP1R agonists for type 2 diabetes therapy.
Graham GV; Conlon JM; Abdel-Wahab YH; Flatt PR
Peptides; 2018 Dec; 110():19-29. PubMed ID: 30391422
[TBL] [Abstract][Full Text] [Related]
6. Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with
Esser N; Mongovin SM; Parilla J; Barrow BM; Mundinger TO; Fountaine BS; Larmore MJ; Castillo JJ; Akter R; Hull RL; Zraika S
Am J Physiol Endocrinol Metab; 2022 Mar; 322(3):E307-E318. PubMed ID: 35128957
[TBL] [Abstract][Full Text] [Related]
7. A Novel GLP1 Receptor Interacting Protein ATP6ap2 Regulates Insulin Secretion in Pancreatic Beta Cells.
Dai FF; Bhattacharjee A; Liu Y; Batchuluun B; Zhang M; Wang XS; Huang X; Luu L; Zhu D; Gaisano H; Wheeler MB
J Biol Chem; 2015 Oct; 290(41):25045-61. PubMed ID: 26272612
[TBL] [Abstract][Full Text] [Related]
8. Sustained expression of GLP-1 receptor differentially modulates β-cell functions in diabetic and nondiabetic mice.
Kubo F; Miyatsuka T; Sasaki S; Takahara M; Yamamoto Y; Shimo N; Watada H; Kaneto H; Gannon M; Matsuoka TA; Shimomura I
Biochem Biophys Res Commun; 2016 Feb; 471(1):68-74. PubMed ID: 26854076
[TBL] [Abstract][Full Text] [Related]
9. Dual-agonist incretin peptides from fish with potential for obesity-related Type 2 diabetes therapy - A review.
Conlon JM; O'Harte FPM; Flatt PR
Peptides; 2022 Jan; 147():170706. PubMed ID: 34861327
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor E2F1 controls the GLP-1 receptor pathway in pancreatic β cells.
Bourouh C; Courty E; Rolland L; Pasquetti G; Gromada X; Rabhi N; Carney C; Moreno M; Boutry R; Caron E; Benfodda Z; Meffre P; Kerr-Conte J; Pattou F; Froguel P; Bonnefond A; Oger F; Annicotte JS
Cell Rep; 2022 Aug; 40(6):111170. PubMed ID: 35947949
[TBL] [Abstract][Full Text] [Related]
11. Development and characterisation of a novel glucagon like peptide-1 receptor antibody.
Biggs EK; Liang L; Naylor J; Madalli S; Collier R; Coghlan MP; Baker DJ; Hornigold DC; Ravn P; Reimann F; Gribble FM
Diabetologia; 2018 Mar; 61(3):711-721. PubMed ID: 29119245
[TBL] [Abstract][Full Text] [Related]
12. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice.
McKillop AM; Moran BM; Abdel-Wahab YH; Gormley NM; Flatt PR
Diabetologia; 2016 Dec; 59(12):2674-2685. PubMed ID: 27677765
[TBL] [Abstract][Full Text] [Related]
14. Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities.
Graham GV; Conlon JM; Abdel-Wahab YH; Flatt PR
Eur J Pharmacol; 2020 Jul; 878():173101. PubMed ID: 32320703
[TBL] [Abstract][Full Text] [Related]
15. The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs.
Smith EP; An Z; Wagner C; Lewis AG; Cohen EB; Li B; Mahbod P; Sandoval D; Perez-Tilve D; Tamarina N; Philipson LH; Stoffers DA; Seeley RJ; D'Alessio DA
Cell Metab; 2014 Jun; 19(6):1050-7. PubMed ID: 24836562
[TBL] [Abstract][Full Text] [Related]
16. GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration.
Ackeifi C; Wang P; Karakose E; Manning Fox JE; González BJ; Liu H; Wilson J; Swartz E; Berrouet C; Li Y; Kumar K; MacDonald PE; Sanchez R; Thorens B; DeVita R; Homann D; Egli D; Scott DK; Garcia-Ocaña A; Stewart AF
Sci Transl Med; 2020 Feb; 12(530):. PubMed ID: 32051230
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptides-1 from phylogenetically ancient fish show potent anti-diabetic activities by acting as dual GLP1R and GCGR agonists.
Graham GV; Conlon JM; Abdel-Wahab YH; Flatt PR
Mol Cell Endocrinol; 2019 Jan; 480():54-64. PubMed ID: 30312651
[TBL] [Abstract][Full Text] [Related]
18. DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats.
Matsumoto K; Yoshitomi T; Ishimoto Y; Tanaka N; Takahashi K; Watanabe A; Chiba K
J Pharmacol Exp Ther; 2018 Dec; 367(3):509-517. PubMed ID: 30217957
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor.
Douros JD; Lewis AG; Smith EP; Niu J; Capozzi M; Wittmann A; Campbell J; Tong J; Wagner C; Mahbod P; Seeley R; D'Alessio DA
Diabetes; 2018 Aug; 67(8):1504-1511. PubMed ID: 29759973
[TBL] [Abstract][Full Text] [Related]
20. Insulinoma induces a hyperinsulinemia-mediated decrease of GLUT2 and GLP1 receptor in normal pancreatic β-cells.
Sho H; Fukui K; Yoneda S; Toyoda S; Ozawa H; Ishibashi C; Fujita Y; Eguchi H; Kozawa J; Shimomura I
Biochem Biophys Res Commun; 2021 Jan; 534():702-706. PubMed ID: 33199025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
